Who
James L. Herman
VP and Chief Compliance Office
Company insider
Files Form 4 as: VP and Chief Compliance Office, Cumberland Pharmaceuticals.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Mar 2013
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $7,0002,500 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $7,0002,500 at $2.80 | filing |
| 17 Mar 2025filed 18 Mar 2025 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $13K2,500 at $5.17 | filing |
| 25 Mar 2024filed 26 Mar 2024 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $6,8404,000 at $1.71 | filing |
| 23 Mar 2024filed 26 Mar 2024 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,1471,186 at $1.81 | filing |
| 24 Mar 2023filed 27 Mar 2023 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 18 Mar 2023filed 21 Mar 2023 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,4581,280 at $1.92 | filing |
| 20 Mar 2022filed 29 Apr 2022 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $3,5071,280 at $2.74 | filing |
| 16 Mar 2022filed 29 Apr 2022 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Mar 2021filed 11 Jun 2021 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 17 Mar 2021filed 11 Jun 2021 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $8,2432,560 at $3.22 | filing |
| 23 Mar 2020filed 17 Apr 2020 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $14K4,000 at $3.56 | filing |
| 18 Mar 2020filed 17 Apr 2020 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $4,1411,173 at $3.53 | filing |
| 26 Nov 2019filed 29 Nov 2019 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $11K2,149 at $4.93 | filing |
| 22 Mar 2019filed 22 Mar 2019 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $18K3,000 at $5.98 | filing |
| 22 Mar 2019filed 22 Mar 2019 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $12K2,066 at $5.62 | filing |
| 23 Mar 2018filed 23 Mar 2018 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $20K3,000 at $6.70 | filing |
| 23 Mar 2018filed 23 Mar 2018 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $20K2,999 at $6.70 | filing |
| 7 Apr 2017filed 7 Apr 2017 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $39K6,000 at $6.45 | filing |
| 7 Apr 2017filed 7 Apr 2017 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $12K1,796 at $6.45 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.